Skip to content

Xencor XNCR Price / sales

Price / sales at other companies

Amgen logo
AmgenAMGN
5.1×+0.2×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.5×+0.6×
Janux Therapeutics logo
Janux TherapeuticsJANX
61.6×-109×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
13.4×-15.4×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
6.9×+1.8×
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
461.8×

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Calculated from Xencor’s reported figures.

Based on the most recent quarter.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's price / sales?
Xencor (XNCR) reported price / sales of 9.1× in Q1 2026.
How has Xencor's price / sales changed year-over-year?
Xencor's price / sales increased by 54.2% year-over-year, from 5.9× to 9.1×.
What is the long-term trend for Xencor's price / sales?
Over 5 years (2020 to 2025), Xencor's price / sales has grown at a -16.0% compound annual growth rate (CAGR), from 20.8× to 8.7×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.